HFA 24: Remote Patient Monitoring for Patients With Heart Failure: TELESAT

HFA 2024 — Investigator, Prof Nicolas Girerd (University Hospital of Nancy, FR) joins us to discuss the findings from the TELESAT study (NCT06312501).

This multicenter observational longitudinal cohort study investigated whether a Remote Patient Monitoring (RPM) program (Satelia®Cardio, Satelia) is able to prevent cardiac decompensation by detecting weak signals of decompensation early in patients with chronic heart failure in France. The study enrolled 20,000 participants with heart failure, with the primary outcome being all-cause death from August 2018 to December 2021.

Findings showed an association between RPM programmes and lower all-cause mortality (35% reduction) based on weight and symptoms evaluation coupled with tele-education.

Interview Questions:

What was the reasoning behind this trial?
What was the patient population and study design?
What were the key results revealed at HFA 24?
How should these findings impact practice and future research?
What surprised you about the results of TELESAT study?
Recorded on-site at HFA 2024, Lisbon.

Visit Radcliffe Cardiology: https://www.radcliffecardiology.com/
Visit Radcliffe Vascular: https://www.radcliffevascular.com/

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.

Like us on Facebook:   / radcliffecardiology  
Follow us on X: https://x.com/radcliffeCARDIO